Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
Adenosine Diphosphate Ribose
/ metabolism
Cloning, Molecular
DNA
/ metabolism
DNA Damage
DNA Polymerase beta
/ metabolism
DNA Repair
DNA-(Apurinic or Apyrimidinic Site) Lyase
/ metabolism
Escherichia coli
/ genetics
Poly (ADP-Ribose) Polymerase-1
/ metabolism
Protein Binding
X-ray Repair Cross Complementing Protein 1
/ metabolism
Apurinic/apyrimidinic endonuclease 1
Base excision repair
Poly(ADP-ribose) polymerase 1
Posttranslational modification
Protein ADP-ribosylation
Journal
Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
09
07
2019
accepted:
22
10
2019
pubmed:
2
11
2019
medline:
9
4
2020
entrez:
1
11
2019
Statut:
ppublish
Résumé
Apurinic/apyrimidinic endonuclease 1 (APE1) is an essential multifunctional protein in mammals involved in base excision DNA repair (BER), regulation of gene expression and RNA metabolism. Its major enzymatic function is incision of AP sites. Poly(ADP-ribose) polymerase 1 (PARP1) modifies itself and target proteins with poly(ADP-ribose) (PAR), contributing to regulation of many processes. To understand molecular basis of functional cooperation between APE1 and PARP1 in BER, we examined PAR-binding activity and ADP-ribosylation of human APE1 in comparison with known targets of PARP1, using the full-length, N-terminally truncated and catalytically inactive forms of APE1. The protein binds preferentially large ADP-ribose polymers, being very similar to DNA polymerase β (Polβ) but contrasting with the scaffold XRCC1 protein. The interaction with PAR involves the universally conserved catalytic portion and the eukaryote-specific extension of APE1. The ADP-ribosylation of APE1 depends on the structure of PARP1-activating DNA, contrasting APE1 with Polβ and XRCC1. Relative levels of APE1 modification in the presence of different DNA substrates were found to correlate with affinities of the DNAs for APE1 and substrate activities in the enzymatic incision, suggesting the ADP-ribosylation to occur within the DNA-mediated ternary complex. This conclusion was confirmed by importance of the length of DNA region 3' to the AP site for the modification. Deletion of the N-terminal extension of APE1 produced no significant influence on both the ADP-ribosylation efficiency and hydrolytic stability of the modified protein, suggesting localization of target amino acids in the conserved catalytic portion. The most efficient ADP-ribosylation of the catalytically inactive APE1 mutant was shown to reduce the level of PARP1 automodification, suggesting possible role of APE1 in modulating PARP1 activity. Our data on primary role of DNA in controlling the PARP-catalysed modification provide new insights into mechanisms of protein targeting for ADP-ribosylation.
Identifiants
pubmed: 31668992
pii: S0300-9084(19)30306-2
doi: 10.1016/j.biochi.2019.10.011
pii:
doi:
Substances chimiques
X-ray Repair Cross Complementing Protein 1
0
XRCC1 protein, human
0
Adenosine Diphosphate Ribose
20762-30-5
DNA
9007-49-2
PARP1 protein, human
EC 2.4.2.30
Poly (ADP-Ribose) Polymerase-1
EC 2.4.2.30
Y265C DNA polymerase beta, rat
EC 2.7.7.-
DNA Polymerase beta
EC 2.7.7.7
APEX1 protein, human
EC 4.2.99.18
DNA-(Apurinic or Apyrimidinic Site) Lyase
EC 4.2.99.18
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
144-155Informations de copyright
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.